Dongmei Zhao Selected Research

Cholesterol Ester Transfer Proteins

11/2017	Design, Synthesis, and Biological Evaluation of N,N-Disubstituted-4-Arylthiazole-2-Methylamine Derivatives as Cholesteryl Ester Transfer Inhibitors.
11/2016	Design, synthesis and biological evaluation of novel cholesteryl ester transfer protein inhibitors bearing a cycloalkene scaffold.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dongmei Zhao Research Topics

Disease

40	Neoplasms (Cancer) 01/2024 - 05/2009
5	Infections 03/2023 - 01/2021
5	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2016 - 12/2013
4	Inflammation (Inflammations) 07/2020 - 12/2011
4	Sepsis (Septicemia) 12/2017 - 12/2011
3	Breast Neoplasms (Breast Cancer) 01/2023 - 05/2010
3	Carcinogenesis 12/2022 - 05/2009
3	Spinal Cord Injuries (Spinal Cord Injury) 04/2022 - 01/2015
3	Mycoses (Diseases, Fungus) 01/2021 - 11/2016
3	Body Weight (Weight, Body) 01/2021 - 12/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 11/2016
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 02/2017 - 09/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 12/2016
2	Endometritis 01/2024 - 01/2021
2	Liver Neoplasms (Liver Cancer) 07/2023 - 06/2015
2	Lymphoma (Lymphomas) 03/2023 - 09/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 07/2022
2	Candidiasis (Moniliasis) 12/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 07/2022 - 07/2022
2	Lung Neoplasms (Lung Cancer) 06/2022 - 04/2016
2	Pneumonia (Pneumonitis) 03/2022 - 02/2017
2	Lung Injury 03/2022 - 02/2017
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 05/2021
2	Healthcare-Associated Pneumonia 02/2021 - 02/2019
2	Obesity 01/2021 - 02/2017
2	Stomach Neoplasms (Stomach Cancer) 11/2019 - 04/2012
2	Leukemia 01/2019 - 06/2013
2	Endotoxemia 12/2017 - 11/2016
2	Acute Lung Injury 02/2017 - 12/2012
2	Insulin Resistance 02/2017 - 09/2013
2	Autism Spectrum Disorder 01/2017 - 06/2015
1	Adenocarcinoma 01/2024
1	Pain (Aches) 10/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2023
1	Autosomal Dominant 5 Deafness 07/2023
1	Disease Resistance 06/2023
1	Disease Progression 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Autosomal Dominant Polycystic Kidney (ADPKD) 12/2022
1	Neuroinflammatory Diseases 12/2022

Drug/Important Bio-Agent (IBA)

16	Phosphotransferases (Kinase)IBA 11/2023 - 04/2016
9	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2014
6	TropomyosinIBA 11/2023 - 11/2021
5	LipopolysaccharidesIBA 01/2024 - 12/2012
5	Lysine (L-Lysine)FDA Link 09/2022 - 08/2021
5	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017 - 09/2010
4	rho-Associated KinasesIBA 03/2022 - 07/2013
3	Focal Adhesion Protein-Tyrosine KinasesIBA 11/2023 - 01/2020
3	Carbapenems (Carbapenem Antibiotics)IBA 01/2023 - 02/2019
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2022 - 06/2022
3	AzolesIBA 12/2022 - 12/2019
3	Histone DemethylasesIBA 09/2022 - 08/2021
3	p21-Activated KinasesIBA 06/2022 - 04/2012
3	EndotoxinsIBA 02/2017 - 12/2011
3	Interleukin-22 (IL-22)IBA 10/2016 - 09/2014
3	Actin Depolymerizing Factors (Cofilins)IBA 04/2016 - 04/2012
3	Heparin (Liquaemin)FDA LinkGeneric 07/2013 - 12/2011
2	Therapeutic UsesIBA 01/2024 - 12/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2023 - 01/2020
2	snake venom protein C activatorIBA 01/2023 - 07/2022
2	Proteolysis Targeting ChimeraIBA 01/2023 - 07/2022
2	Flavin-Adenine Dinucleotide (FAD)IBA 09/2022 - 08/2021
2	Protein Kinases (Protein Kinase)IBA 08/2022 - 07/2022
2	CalciumIBA 04/2022 - 01/2022
2	Glutathione (Reduced Glutathione)IBA 01/2022 - 01/2020
2	DisulfidesIBA 01/2022 - 01/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 09/2010
2	EnzymesIBA 08/2021 - 08/2015
2	AntioxidantsIBA 07/2020 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 12/2010
2	Cholesterol Ester Transfer ProteinsIBA 11/2017 - 11/2016
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 04/2017 - 10/2016
2	Insulin (Novolin)FDA Link 02/2017 - 09/2013
2	CytokinesIBA 10/2016 - 12/2013
2	Cyclin D1IBA 04/2016 - 04/2012
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2015 - 06/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 09/2013
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2011 - 01/2011
2	Dextrans (Dextran)FDA Link 11/2011 - 01/2011
2	CamptothecinIBA 11/2011 - 01/2011
1	Sorafenib (BAY 43-9006)FDA Link 01/2024
1	Rosiglitazone (Avandia)FDA Link 01/2024
1	Ropivacaine (Naropin)FDA LinkGeneric 10/2023
1	Morphine (MS Contin)FDA LinkGeneric 10/2023
1	belimumabIBA 08/2023
1	Aflatoxin B1 (Aflatoxin B)IBA 07/2023
1	CurcuminIBA 07/2023
1	SuspensionsIBA 06/2023
1	vidofludimusIBA 03/2023
1	Meropenem (Merrem)FDA LinkGeneric 03/2023
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 03/2023
1	SH-1028IBA 01/2023
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2022

Therapy/Procedure

10	Therapeutics 01/2023 - 10/2016
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2016 - 12/2013
2	Oral Administration 08/2022 - 05/2020
2	Hematopoietic Stem Cell Transplantation 02/2016 - 09/2014
1	Immunotherapy 01/2024
1	Analgesia 10/2023
1	Length of Stay 01/2023